Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Wellbeing Digital Sciences Inc (OP: KONEF )

N/A UNCHANGED
Last Price Updated: 3:57 PM EST, Mar 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Wellbeing Digital Sciences Inc

< Previous 1 2 3 Next >
Wellbeing Subsidiary KGK Science Announces AKL No Objection Status for ProGo® Branded Ingredient from FDA
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary IRP Health Toronto Location Approved by Veterans Affairs Canada for Its Reactivation Program
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Corporate Update in a Letter from the CEO to its Shareholders
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Net Loss Continues To Grow: Q2 Reaches $5.15M, Up By 552% YoY
Wellbeing Digital Sciences Inc. (OTCQB:KONEF 
Via Benzinga
Ketamine One Shares Uplisted To OTCQB
KetamineOne Capital Limited (OTCQB:KONEF), a company ... 
Via Benzinga
KGK Sciences And Halucenex Sign Contract For Phase II Clinical Trial On Psilocybin For PTSD
KGK Sciences Inc., a subsidiary company of psychedelics healthcare researcher and provider Wellbeing Digital Sciences Inc. 
Via Benzinga
Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Introduces Women In Psychedelics, A Network For Female Minds In Psychedelics
Mental healthcare company Wellbeing Digital Sciences Inc. (OTC: KONEF) and its subsidiary KGK Science Inc. are the founding sponsors of the Women in Psychedelics Network, also known as “WIP.” 
Via Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 7, 2022
GAINERS: GH Research (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 4, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 1, 2022
GAINERS: Cybin (AMEX: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 14, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market
Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership With Nova Mentis
The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application  to Health Canada   
Via Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: 
Via Benzinga
Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne
Agrify Taps Barry Turkanis To Its Board Of Directors Vertically integrated cannabis company Agrify Corporation (NASDAQ... 
Via Benzinga
Cannabis Dispensary Roundup: Verano, Jushi, Cresco, KetamineOne
Verano Opens 3rd Jacksonville Area Location and 40th Florida Storefront In Orange Park Verano Holdings Corp. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Dispensary Roundup: Ascend Wellness, Ketamine One, Cresco, Kiaro, TILT, BELLEBUD
Ascend Wellness Opens Second Massachusetts Store in Newton Vertically integrated cannabis company Ascend Wellness Holdings, Inc... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
The Week In Psychedelics: 
Via Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Contents 
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
KetamineOne Capital Forms Medical Advisory Board, Will Oversee Development Of Its Mental-Health Platform
KetamineOne Capital Limited (NEO: MEDI) (OTCPK: 
Via Benzinga
Expanding Mental Health Provider; 15 Clinics in North America & Cutting-Edge Clinical Research Programs: KetamineOne (OTC: KONEF)
Via Get News
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.